Unlocking The Promise Of Biotech Startups
3/6/2014 8:15:11 AM
As an early stage biotech investor, the future of the industry and its structure are clearly important things to think about – especially since most of the drug programs our new startups are working on won’t get launched, if they are the rare success, until well into the 2020’s. A few recent experiences and observations prompted some deeper thinking, in particular around the Startup vs. Big Firm dichotomy and its implications. I’ve boiled these down into three themes.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by